StockMarketWire.com - Barclays Capital today reaffirms its overweight investment rating on Mediclinic International Plc [LON:MDC] and cut its price target to 660p (from 700p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk